One coronavirus pill, which can be taken when the disease first appears, Pfizer may be available for use by the end of 2021.
Speaking to CNBC, the CEO of the pharmaceutical industry, Albert Burla, pointed out that antiviral therapy “is expected to be effective against coronavirus mutations”.
When asked about the Telegraph report which stated that they are being conducted clinical construction in the USA and in Belgium where adult volunteers take a pill to treat Covid-19, Burla admitted that “The article is accurate” and that indeed the Pfizer works on such treatments.
«We test two antiviral drugs, one of which is given intravenously and the other orally. “, he said, adding that Pfizer focuses on oral selection because it “provides many advantages”, mainly that it does not require going to a hospital or other health care provider to receive treatment.
“The possibility of someone receiving antiviral treatment for coronavirus orally in their own home will change the terms of the game,” Burla said.
Asked who he considers as “A reasonable period of time” for the completion of the clinical trial and the availability of the pill, Burla replied: ““If everything goes well, I hope by the end of the year.”
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
